ArticleMolecular oncology2022

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumours.

Juan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.